Cognizant Technology Solutions (CTSH) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
31 Jan, 2026Opening remarks and agenda
Meeting opened with introductions of executive team and board members, and a reminder about forward-looking statements and non-GAAP measures.
The agenda included a review of strategic progress, voting on company and shareholder proposals, and a Q&A session.
Financial performance review
Revenue in Q1 2024 exceeded the high end of guidance, with large deal momentum accelerating compared to the prior year.
Eight large deals (each $100M+ TCV) were signed in Q1 2024, up from four in the year-ago period, with diversification into Asia Pacific and Japan.
Adjusted operating margin in Q1 2024 expanded by 50 basis points year-over-year to 15.1%.
Board and executive committee updates
All 12 director nominees were introduced and participated in the meeting.
Board guidance and support were acknowledged as instrumental in strategic execution.
Latest events from Cognizant Technology Solutions
- Q1 2026 revenue and adjusted EPS rose strongly, with margin guidance raised after Project Leap launch.CTSH
Q1 202629 Apr 2026 - Strong growth, robust governance, and performance-based pay drive strategic progress in 2025.CTSH
Proxy filing17 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and a shareholder rights proposal.CTSH
Proxy filing17 Apr 2026 - Revenue up 7% to $21.1B, margin and EPS rose, with strong bookings and positive 2026 outlook.CTSH
Q4 202513 Apr 2026 - 2026 growth targets hinge on AI adoption, large deals, and sector leadership in BFSI and BPO.CTSH
Morgan Stanley Technology, Media & Telecom Conference 20264 Mar 2026 - AI-led productivity and large deals drive growth amid sector uncertainty and ongoing investment.CTSH
53rd Annual JPMorgan Global Technology, Media and Communications Conference3 Feb 2026 - AI and agentic cycles drive innovation, margin growth, and new outsourcing opportunities.CTSH
Goldman Sachs Communicopia + Technology Conference 20253 Feb 2026 - Q2 revenue beat guidance, margins improved, and Belcan acquisition to expand ER&D.CTSH
Q2 20242 Feb 2026 - $1.29B deal expands ER&D, targets $100M+ synergies, and accelerates aerospace & defense growth.CTSH
M&A Announcement2 Feb 2026